2022
DOI: 10.3390/life13010082
|View full text |Cite
|
Sign up to set email alerts
|

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis

Abstract: Interleukin-1 receptor antagonist (IL-1ra) concentration reflects and is proportional to IL-1 production. Both IL-1 and IL-6 are involved in the pathogenesis of rheumatoid arthritis (RA). However, the relationship of serum levels of these two cytokines to each other in RA patients is not well-understood. In this study, our objective was to analyze the possible linear correlation between IL-1ra and IL-6 in patients with RA, and how both are related to the inflammatory activity of the disease. IL-6 and IL-1ra le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
(28 reference statements)
0
1
0
Order By: Relevance
“…However, there was a clear distinction between direct and indirect co-culture groups as well as low and high levels of IL-1β in co-culture in terms of therapeutic mitigation. Studies have demonstrated that production of IL-1Ra, a natural inhibitor of IL-1, is elevated in in ammatory RA joints [57]; however, the levels produced in RA joints are usually insu cient to reduce damage, as a concentration of 10-to-100-fold excess of IL-1Ra is required to effectively inhibit IL-1, which is a limiting factor for IL-1Ra as a clinical therapeutic [58]. Stimulation with 1 or 10 ng/mL IL-1β used in these experiments represent super-physiological levels as concentrations of IL-1β have been reported between 0.115 to 0.5 ng/mL in the synovial uid in early spontaneous joint degeneration [55].…”
Section: Discussionmentioning
confidence: 99%
“…However, there was a clear distinction between direct and indirect co-culture groups as well as low and high levels of IL-1β in co-culture in terms of therapeutic mitigation. Studies have demonstrated that production of IL-1Ra, a natural inhibitor of IL-1, is elevated in in ammatory RA joints [57]; however, the levels produced in RA joints are usually insu cient to reduce damage, as a concentration of 10-to-100-fold excess of IL-1Ra is required to effectively inhibit IL-1, which is a limiting factor for IL-1Ra as a clinical therapeutic [58]. Stimulation with 1 or 10 ng/mL IL-1β used in these experiments represent super-physiological levels as concentrations of IL-1β have been reported between 0.115 to 0.5 ng/mL in the synovial uid in early spontaneous joint degeneration [55].…”
Section: Discussionmentioning
confidence: 99%